The targeted resveratrol attenuated hepatic steatosis and improved hepatic insulin sensitivity in dietary-induced obese NAFLD mice through modulation of AMPK/SIRT1/FAS/SREBP1c signaling pathway [82]. This evidence concerns the gene INS and fatty liver disease.